Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/21170
Registo completo
Campo DCValorIdioma
degois.publication.firstPage2339por
degois.publication.lastPage2346por
degois.publication.titleEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYpor
dc.contributor.authorSantos, Cledir R.
dc.contributor.authorCapela, Rita
dc.contributor.authorPereira, Claudia S. G. P.
dc.contributor.authorValente, Emilia
dc.contributor.authorGouveia, Luis
dc.contributor.authorPannecouque, Christophe
dc.contributor.authorDe Clercq, Erik
dc.contributor.authorMoreira, Rui
dc.contributor.authorGomes, Paula
dc.date.accessioned2015-12-30T10:17:38Z-
dc.date.available2015-12-30T10:17:38Z-
dc.date.issued2009
dc.identifier.citationEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - Vol. 44, n. 6 (JUN 2009), p. 2339-2346
dc.identifier.issn0223-5234
dc.identifier.urihttp://hdl.handle.net/10451/21170-
dc.description.abstractA series of water-soluble dipeptide ester prodrugs of the antiviral acyclovir (ACV) were evaluated for their chemical stability, cytotoxicity, and antiviral activity against several strains of Herpes Simplex-1 and -2, vaccinia, vesicular stomatitis, cytomegalovirus and varicella zoster viruses. ACV dipeptide esters were very active against herpetic viruses, independently of the rate at which they liberate the parent drug. Their minimum cytotoxic concentrations were above 100 mu M and the resulting MCC/EC50 values were lower than those of ACV. When comparing the reactivity of Phe-Gly esters and amides (ACV, zidovudine, paracetamol, captopril and primaquine) in pH 7.4 buffer it was found that the rate of drug release increases with drug's leaving group ability. Release of the parent drug from Phe-Gly in human plasma is markedly faster than in pH 7.4 buffer, thus suggesting that the dipeptide-based prodrug approach can be successfully applied to bioactive agents containing thiol, phenol and amine functional groups. (C) 2008 Elsevier Masson SAS. All rights reserved.. - Funda Ao para a Ciencia e Tecnologia (Portugal) ; CIQUP (PG) ; [SFRHBD/9277/2002]. - Thanks are due to Funda Ao para a Ciencia e Tecnologia (Portugal) for financial support through plurianual funding of research units CIQUP (PG), iMed.UL (RM) and through doctoral grant SFRHBD/9277/2002 (CRS). The authors also thank MEDINFAR for kindly offering acyclovir.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
dc.rightsrestrictedAccess
dc.subjectChemistry, Medicinal
dc.titleStructure-activity relationships for dipeptide prodrugs of acyclovir
dc.titleImplications for prodrug design
dc.typearticle
degois.publication.volumeVol. 44por
dc.identifier.doihttp://dx.doi.org/10.1016/j.ejmech.2008.08.009
Aparece nas colecções:FF - Produção Científica 2000-2009

Ficheiros deste registo:
Não existem ficheiros associados a este registo.


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.